Target intelligence / Profile preview

Proton-dependent oligopeptide transporter (POT) (POT)

Target
POT
Molecular classification
Transporter, Major Facilitator Superfamily (MFS), Proton-dependent oligopeptide transporter (POT) family
01

Overview

Bacterial peptide/organic cation transporters, primarily represented by the Proton-dependent Oligopeptide Transporter (POT) family (also known as the PTR family), are integral membrane proteins that facilitate the uptake of di- and tri-peptides from the extracellular environment into the bacterial cytoplasm [2]. These transporters are members of the Major Facilitator Superfamily (MFS) and function as symporters, utilizing the inward-directed proton electrochemical gradient (proton motive force) to drive substrate transport [2, 10]. Beyond their physiological role in nutrient acquisition and nitrogen metabolism, these transporters are of significant pharmacological interest because they can recognize and transport a wide variety of peptidomimetic drugs, including beta-lactam antibiotics like cephalosporins (e.g., cephalexin, cefadroxil) and various peptide-conjugated prodrugs [2, 11]. By hijacking these nutrient uptake pathways, these drugs can achieve high intracellular concentrations, which is essential for their antimicrobial efficacy [2]. The study of bacterial POTs, such as DtpA from Escherichia coli, has provided critical structural and functional insights into the mechanism of peptide transport, serving as a model for understanding human homologs like PEPT1 and PEPT2 [6, 10]. Consequently, these transporters are considered important targets for improving drug delivery and overcoming certain types of bacterial resistance [2, 11].

Other names
Peptide transport (PTR) familyBacterial peptide/organic cation transportersDi- and tripeptide permeaseDtp familySLC15 homologsProton-coupled oligopeptide transporter
02

Mechanism of action

Facilitated uptake of peptidomimetic drugs via proton-coupled symport

03

Biological functions

Nutrient uptakeProton-coupled symportPeptide metabolismNitrogen source acquisition
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Competition with natural peptidesPotential for drug-drug interactionsCross-reactivity with human PEPT1/2 (SLC15A1/2)
06

Interacting drugs

Cephalexin

6 more in the full profile.

07

Biomarkers

DtpA expression levelDtpB expression levelProton motive force (PMF) status

Beyond the preview

Go deeper on Proton-dependent oligopeptide transporter (POT) (POT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proton-dependent oligopeptide transporter (POT) (POT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call